Can you get medical cannabis for cancer pain in the UK?

Cancer-related pain and palliative symptom control are among the conditions UK specialists consider. Two things need saying at the outset: this is about symptoms, not about treating cancer, and the randomised evidence in cancer pain is weaker than many people expect.

Is cancer pain treated with medical cannabis in the UK?

Cancer-related pain and palliative symptoms are assessed by specialists, and cancer patients are among those UK private clinics see. Nothing is licensed for cancer pain, and the honest position is that this sits at the edges of symptom control rather than at its centre.

UK cancer pain is managed by oncology and palliative care teams, who have a well-established toolkit — opioids, adjuvant medicines, nerve blocks, radiotherapy for bone pain, and specialist palliative input. Those services should lead. A cannabis-based medicine, if it has a place, sits alongside them for symptoms that persist despite proper treatment.

There is no good evidence that cannabis or cannabinoids treat cancer, shrink tumours, or extend life. Claims to the contrary circulate widely and are not supported by clinical trials. Nothing on this page should delay or displace cancer treatment.

What the evidence actually shows

Cancer pain has been studied in reasonably large randomised trials, and the pooled result is not encouraging. This is one of the few conditions on this site where the evidence is substantial enough to give a fairly confident negative answer.

A Cochrane systematic review of cannabis-based medicines and medical cannabis for adults with cancer pain, published in 2023, pooled the randomised evidence and found no clear benefit over placebo on pain relief, alongside more adverse events. Earlier individual trials of a THC:CBD oromucosal spray in opioid-treated cancer patients produced mixed results, with some signals in secondary analyses that were not confirmed in later, larger studies.

Where cannabis-based medicines are used in palliative settings in the UK, the rationale is usually broader than pain — nausea, appetite, sleep, distress — and is a matter of individual clinical judgement in someone with limited options, not an evidence-based standard of care.

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For cancer-related pain they will typically look at:

• Your cancer diagnosis, treatment stage, and who is leading your care
• Whether specialist palliative care has been involved, and what has already been tried for pain
• Your current analgesia, particularly opioid type and dose, and how well it is working
• Which symptom is the priority: pain, nausea, appetite, sleep, or distress
• Your full medicine list, since interactions and combined sedation matter a great deal here
• Whether treatment is realistically going to add to what your existing team can offer

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

People with cancer are usually taking several medicines, are often frail, and may have liver or kidney impairment that changes how a medicine is handled. That makes interactions and sedation a bigger issue than in most other conditions on this site.

The Cochrane review also found more adverse events with cannabis-based medicines than placebo in cancer pain — which, in the absence of clear benefit, is the part that should carry weight. Drowsiness, dizziness, confusion, nausea and dry mouth are the common ones. A responsible specialist will coordinate with your oncology or palliative team rather than prescribing in parallel with them, and will be clear that the aim is comfort, not disease control.

How a cannabis-based medicine is thought to help

The body has an endocannabinoid system — a network of signalling molecules and receptors that helps regulate pain, nausea, appetite, mood and sleep. Cannabis-based medicines contain compounds that interact with this system, and in a palliative setting the rationale is usually about several of these symptoms together rather than pain alone.

It is important to keep the limits of that idea in view. A plausible mechanism is not the same as benefit, and in cancer pain the pooled randomised evidence has not shown a clear advantage over placebo. This does not treat the cancer. The two main compounds are thought to act differently — one intoxicating and more associated with pain, nausea and sleep effects, the other not intoxicating — and a specialist weighs them against your other medicines and how you are coping. The biology is explained plainly in the endocannabinoid system explained and THC and CBD explained.

What treatment involves in practice

Where a specialist judges a trial reasonable, it starts at a low dose that is increased slowly under supervision, most often as an oil or capsule taken by mouth. Because the evidence here is weak and adverse events are more common, the emphasis is on close monitoring and a clear review point rather than on escalating quickly.

Coordination is central in cancer care. Any cannabis-based medicine should sit alongside the plan your oncology and palliative teams are running, not in parallel with it, so that analgesia, anti-sickness medicines and sedation are managed as a whole. How these medicines are taken is covered in how cannabis-based medicines are taken, and how a dose is set and adjusted in how a dose is decided and adjusted.

At each review your specialist checks whether the target symptom — pain, nausea, appetite, sleep or distress — has genuinely improved, and weighs that against side effects such as drowsiness or confusion. If it is not adding comfort, stopping is the right call. For symptoms other than pain, see nausea and appetite loss.

Questions worth asking your specialist

Because the aim here is comfort rather than cure, and interactions matter a great deal, a few direct questions help keep any trial safe and realistic.

• Which symptom are we actually trying to improve, and what would success look like?
• How will this be coordinated with my oncology and palliative care teams?
• How might it interact with my current pain and anti-sickness medicines?
• What side effects should I watch for, and which ones mean I should call you?
• At what review point would we decide to continue or stop?
• Is this realistically going to add to what my existing team can already offer?

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If cancer-related pain is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026